Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionPrivate Trust Co Na
Latest Disclosed Ownership27,807 shares
Latest Disclosed Value $ 1,686,502
Private Trust Co Na reports 1.48% decrease in ownership of BRM / Bristol-Myers Squibb Company

On April 30, 2026 - Private Trust Co Na filed a 13F-HR form disclosing ownership of 27,807 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,457,643 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 28,226 shares of Bristol-Myers Squibb Company. This represents a change in shares of -1.48% during the quarter. The current value of the position is $1,318,886 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F Bristol-Myers Squibb Com 110122108 27,807 -419 -1.48 1,687 10.78 0.1506
2026-01-26 2025-12-31 13F Bristol-Myers Squibb Com 110122108 28,226 -619 -2.15 1,522 17.08 0.1334
2025-10-15 2025-09-30 13F Bristol-Myers Squibb Com 110122108 28,845 -1,845 -6.01 1,301 -8.45 0.1147
2025-07-29 2025-06-30 13F Bristol-Myers Squibb Com 110122108 30,690 -1,139 -3.58 1,421 -26.84 0.1353
2025-04-28 2025-03-31 13F Bristol-Myers Squibb Com 110122108 31,829 -1,514 -4.54 1,941 2.97 0.1998
2025-02-05 2024-12-31 13F Bristol-Myers Squibb Com 110122108 33,343 -605 -1.78 1,886 7.35 0.1936
2024-11-13 2024-09-30 13F Bristol-Myers Squibb Com 110122108 33,948 -3,531 -9.42 1,756 12.85 0.1770
2024-07-23 2024-06-30 13F Bristol-Myers Squibb Com 110122108 37,479 -3,173 -7.81 1,556 -29.40 0.1676
2024-04-24 2024-03-31 13F Bristol-Myers Squibb Com 110122108 40,652 -1,951 -4.58 2,205 0.87 0.2381
2024-01-24 2023-12-31 13F Bristol-Myers Squibb Com 110122108 42,603 -4,087 -8.75 2,186 -19.34 0.2568
2023-10-18 2023-09-30 13F Bristol-Myers Squibb Com 110122108 46,690 -2,883 -5.82 2,710 -14.54 0.3575
2023-07-28 2023-06-30 13F Bristol-Myers Squibb Com 110122108 49,573 -766 -1.52 3,170 -9.14 0.3998
2023-04-12 2023-03-31 13F Bristol-Myers Squibb Com 110122108 50,339 1,307 2.67 3,489 116,200.00 0.4756
2023-01-18 2022-12-31 13F Bristol-Myers Squibb Com 110122108 49,032 -1,476 -2.92 4 -99.92 0.5235
2022-10-17 2022-09-30 13F Bristol-Myers Squibb Com 110122108 50,508 -2,519 -4.75 3,591 -12.05 0.5833
2022-09-16 2022-06-30 13F/A-1 Bristol-Myers Squibb Com 110122108 53,027 492 0.94 4,083 6.41 0.6340
2022-07-13 2022-06-30 13F Bristol-Myers Squibb Equities 110122108 52,535 0 3,837 0.5993
2022-04-12 2022-03-31 13F Bristol-Myers Squibb Equities 110122108 52,535 -2,610 -4.73 3,837 11.61 0.5993
2022-01-10 2021-12-31 13F Bristol-Myers Squibb Equities 110122108 55,145 3,056 5.87 3,438 11.55 0.4746
2021-10-06 2021-09-30 13F Bristol-Myers Squibb Equities 110122108 52,089 7,467 16.73 3,082 3.35 0.4486
2021-07-07 2021-06-30 13F Bristol-Myers Squibb Equities 110122108 44,622 -215 -0.48 2,982 5.37 0.4518
2021-04-06 2021-03-31 13F Bristol-Myers Squibb Equities 110122108 44,837 559 1.26 2,830 3.06 0.4597
2021-01-05 2020-12-31 13F Bristol-Myers Squibb Equities 110122108 44,278 -682 -1.52 2,746 1.33 0.4625
2020-10-01 2020-09-30 13F Bristol-Myers Squibb Equities 110122108 44,960 1,467 3.37 2,710 3.55 0.5228
2020-07-07 2020-06-30 13F Bristol-Myers Squibb Equities 110122108 43,493 2,088 5.04 2,617 13.44 0.5487
2020-04-07 2020-03-31 13F Bristol-Myers Squibb Equities 110122108 41,405 -793 -1.88 2,307 -14.81 0.5970
2020-01-02 2019-12-31 13F Bristol-Myers Squibb Equities 110122108 42,198 6,363 17.76 2,708 49.04 0.5024
2019-10-01 2019-09-30 13F Bristol-Myers Squibb Equities 110122108 35,835 -2,081 -5.49 1,817 5.70 0.3582
2019-07-02 2019-06-30 13F Bristol-Myers Squibb Equities 110122108 37,916 -1,096 -2.81 1,719 -7.63 0.3467
2019-04-02 2019-03-31 13F Bristol-Myers Squibb Equities 110122108 39,012 141 0.36 1,861 -7.87 0.3871
2019-01-03 2018-12-31 13F Bristol-Myers Squibb Equities 110122108 38,871 -7,671 -16.48 2,020 -30.08 0.4797
2018-10-09 2018-09-30 13F Bristol-Myers Squibb Equities 110122108 46,542 -1,114 -2.34 2,889 9.56 0.5895
2018-07-03 2018-06-30 13F Bristol-Myers Squibb Equities 110122108 47,656 -15,182 -24.16 2,637 -33.64 0.5716
2018-04-03 2018-03-31 13F Bristol-Myers Squibb Equities 110122108 62,838 841 1.36 3,974 4.61 0.8686
2018-01-16 2017-12-31 13F Bristol-Myers Squibb Equities 110122108 61,997 -1,991 -3.11 3,799 -6.84 0.8039
2017-10-12 2017-09-30 13F Bristol-Myers Squibb Equities 110122108 63,988 -36 -0.06 4,078 14.33 0.8876
2017-07-11 2017-06-30 13F Bristol-Myers Squibb Equities 110122108 64,024 -7,872 -10.95 3,567 -8.75 0.7779
2017-04-13 2017-03-31 13F Bristol-Myers Squibb Equities 110122108 71,896 -1,270 -1.74 3,909 -8.56 0.9036
2017-01-17 2016-12-31 13F Bristol-Myers Squibb Equities 110122108 73,166 -226 -0.31 4,275 8.04 1.0234
2016-10-13 2016-09-30 13F Bristol-Myers Squibb Equities 110122108 73,392 10,246 16.23 3,957 -14.79 0.9644
2016-07-19 2016-06-30 13F Bristol-Myers Squibb Equities 110122108 63,146 -3,675 -5.50 4,644 8.81 1.2080
2016-04-18 2016-03-31 13F Bristol-Myers Squibb Equities 110122108 66,821 2,147 3.32 4,268 -4.05 1.1560
2016-01-19 2015-12-31 13F Bristol-Myers Squibb Equities 110122108 64,674 -282 -0.43 4,448 15.68 1.2669
2015-10-27 2015-09-30 13F Bristol-Myers Squibb Equities 110122108 64,956 1,107 1.73 3,845 -9.49 1.1518
2015-07-10 2015-06-30 13F Bristol-Myers Squibb Equities 110122108 63,849 2,951 4.85 4,248 8.17 1.2177
2015-04-09 2015-03-31 13F Bristol-Myers Squibb Equities 110122108 60,898 60,898 0.00 3,927 1.1245
2015-01-28 2014-12-31 13F Bristol-Myers Squibb Com 110122108 0 -43,023 -100.00 0 -100.00
2014-10-09 2014-09-30 13F Bristol-Myers Squibb Com 110122108 43,023 -1,149 -2.60 2,202 2.75 0.7476
2014-07-22 2014-06-30 13F Bristol-Myers Squibb Com 110122108 44,172 9,011 25.63 2,143 17.30 0.6978
2014-04-07 2014-03-31 13F Bristol-Myers Squibb Com 110122108 35,161 -618 -1.73 1,827 -3.94 0.6890
2014-01-08 2013-12-31 13F Bristol-Myers Squibb Com 110122108 35,779 -39,787 -52.65 1,902 -45.61 0.7651
2013-10-07 2013-09-30 13F Bristol-Myers Squibb Com 110122108 75,566 13,475 21.70 3,497 26.02 1.5818
2013-08-01 2013-06-30 13F Bristol-Myers Squibb Com 110122108 62,091 0 0.00 2,775 0.00 1.2741
2013-07-26 2013-03-31 13F Bristol-Myers Squibb Com 110122108 62,091 62,091 2,775 1.2741
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.